| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Rat/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-V-set and transmembrane domain-containing protein 1 (170-220 aa) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
VSTM1 |
| Gene ID: |
284415 |
| Uniprot ID: |
VSTM1_HUMAN |
| Immunogen Region: |
170-220 aa |
| Specificity: |
This antibody detects endogenous levels of VSTM1 at Human |
| Immunogen: |
Synthesized peptide derived from the human VSTM1 at the amino acid range 170-220 |
| Post Translational Modifications | Isoform 2 is N-glycosylated. |
| Function | Isoform 2: Behaves as a cytokine, promoting IL17A secretion by CD4+ T-cells, and differentiation and activation of IL17 producing helper T-cells (TH17). Isoform 1: Inhibitory immune receptor involved in the regulation of phagocytes. |
| Protein Name | V-Set And Transmembrane Domain-Containing Protein 1Signal Inhibitory Receptor On Leukocytes-1Sirl-1 |
| Cellular Localisation | Isoform 1: MembraneSingle-Pass Membrane ProteinIsoform 2: Secreted |
| Alternative Antibody Names | Anti-V-Set And Transmembrane Domain-Containing Protein 1 antibodyAnti-Signal Inhibitory Receptor On Leukocytes-1 antibodyAnti-Sirl-1 antibodyAnti-VSTM1 antibodyAnti-UNQ3033 antibodyAnti-PRO9835 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
